Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations (Q36767153)

16 August 2017

1 reference

title

Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations (English)

1 reference

management recommendation

16 August 2017

1 reference

1 reference

inferred from title

author name string

Inger von Bültzingslöwen

1

1 reference

16 August 2017

Thomas P Sollecito

2

1 reference

16 August 2017

Philip C Fox

3

1 reference

16 August 2017

Troy Daniels

4

1 reference

16 August 2017

Roland Jonsson

5

1 reference

16 August 2017

Peter B Lockhart

6

1 reference

16 August 2017

David Wray

7

1 reference

16 August 2017

Michael T Brennan

8

1 reference

16 August 2017

Marco Carrozzo

9

1 reference

16 August 2017

Beatrice Gandera

10

1 reference

16 August 2017

Takashi Fujibayashi

11

1 reference

16 August 2017

Mahvash Navazesh

12

1 reference

16 August 2017

Nelson L Rhodus

13

1 reference

16 August 2017

Morten Schiødt

14

1 reference

16 August 2017

1 March 2007

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

16 August 2017

1 reference

16 August 2017

103 Suppl

1 reference

16 August 2017

S57.e1-15

1 reference

Evaluation of submandibular salivary flow rate in different age groups

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Longitudinal influence of age, menopause, hormone replacement therapy, and other medications on parotid flow rates in healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Aging and Secretory Reserve Capacity of Major Salivary Glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Treatment of xerostomia: a systematic review of therapeutic trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Progression of sialadenitis in Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral health condition and saliva flow in southern Chinese with Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Increased Risk of Lymphoma in Sicca Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The risk of lymphoma development in autoimmune diseases: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral and salivary parameters in patients with rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

A prospective study of sicca symptoms in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Sialochemistry in juvenile idiopathic arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Whole saliva in systemic lupus erythematosus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Histologic and sialochemical findings indicating sicca syndrome in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Primary biliary cirrhosis, sicca complex, and dysphagia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Bilateral parotid swelling caused by sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Sicca syndrome in patients with sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Xerostomia in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Type 1 diabetes mellitus, xerostomia, and salivary flow rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary characteristics of diabetic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Effects of diabetes mellitus on salivary secretion and its composition in the human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

A longitudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Neural regulation of submandibular gland blood flow in the streptozotocin-diabetic rat: evidence for impaired endothelium-dependent vasodilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Natural history of HIV-associated salivary gland disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Longitudinal evaluation of major salivary gland function in HIV-1 infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Longitudinal study of parotid saliva in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Alteration in salivary function in early HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Hepatitis C virus and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Mild sialoadenitis: a common finding in patients with hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Hepatitis C infection and associated oral health problems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral health of patients with hepatitis C virus infection: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Whole stimulated salivary flow in patients with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral diseases possibly associated with hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary gland function in persons with ectodermal dysplasias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Aplasia of submandibular salivary glands associated with ectodermal dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The parotid puzzle: a review of the literature on human salivation and its applications to psychophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Depressive symptoms in individuals with idiopathic subjective dry mouth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Depressive symptoms as an underlying factor of the sensation of dry mouth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Objective evidence of decreased salivary function in patients with autoimmune thyroiditis (chronic thyroiditis, Hashimoto's thyroiditis).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary gland involvement in autoimmune thyroiditis, with special reference to the degree of association with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary IgA antigliadin antibody as a marker for coeliac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Changes in whole saliva in patients with coeliac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary SIgA and SIgA 1 in coeliac disease, inflammatory bowel disease and controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Increased salivary buffering in association with a low caries experience in children suffering from cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Lipid composition of submandibular saliva from normal and cystic fibrosis individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Stimulated parotid salivary flow rate in patients with Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Evaluation of the relationship between caries indices and salivary secretory IgA, salivary pH, buffering capacity and flow rate in children with Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Composition, flow-rate and pH of mixed and parotid salivas from trisomic 21 and other mentally retarded subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary sialic acid, protein, salivary flow rate, pH, buffering capacity and caries indices in subjects with Down's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary hypofunction in patients with familial amyloidotic polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral sugar clearance and other caries-related factors in patients with myotonic dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The Papillon-Lefèvre syndrome: keratosis palmoplantaris with periodontopathy. Report of a case and review of the cases in the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Saliva composition in children and young adults with Papillon-Lefèvre syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary abnormalities in Prader-Willi syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Decreased salivary output in patients with Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Amyloidosis: diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Primary salivary gland amyloidosis causing sicca syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Case report: sicca syndrome due to primary amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Etiologies of the sicca syndrome: primary systemic amyloidosis and others.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Sicca syndrome due to amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary iron status in children with iron deficiency and iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The relationship between dehydration and parotid salivary gland function in young and older healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Parotid Salivary Secretory Pattern in Bulimia Nervosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Decreased salivary function in patients with end-stage renal disease requiring hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary function in patients with chronic renal failure undergoing hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Hyposalivation and iron stores among individuals with and without active dental caries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary flow and dental caries in Indian children suffering from chronic malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Effect of pilocarpine mouthwash on salivary flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Randomized-controlled trial: effect of a reservoir biteguard on quality of life in xerostomia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Acupuncture in xerostomia--a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary enhancement therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Review of the Pharmacological Properties and Clinical Usefulness of Muscarinic Agonists for Xerostomia in Patients with Sjögren's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

RETRACTED: Infliximab in primary Sjögren's syndrome: one-year followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The use of oral pilocarpine in xerostomia and Sjögren's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

The effect of acupuncture on salivary flow rates in patients with xerostomia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Acupuncture treatment of patients with radiation-induced xerostomia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Application of microchip assay system for the measurement of C-reactive protein in human saliva.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Sjogrens syndrome--the non-apoptotic model of glandular hypofunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Salivary gland aplasia: an ectodermal disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

Characteristics of rheumatoid arthritis patients with self-reported sicca symptoms: evaluation of medical, salivary and oral parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

7 January 2021

inferred from DOI database lookup

Castillo-Morales' Orofacial Therapy: Treatment of 67 Children with Down Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

7 January 2021

inferred from DOI database lookup

Flow rate and chemistry of parotid saliva related to dental caries and gingivitis in patients with thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.010

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.TRIPLEO.2006.11.010

1 reference

16 August 2017

1 reference